News | April 01, 2025
Briefs: AstraZeneca Pharma India, Pharmaids and Dr. Agarwal's Health Care
AstraZeneca Pharma India discontinues manufacturing of Imdur
AstraZeneca Pharma India discontinues manufacturing of Imdur
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Positions Curium as leading manufacturer of Lu-177 isotope
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
Subscribe To Our Newsletter & Stay Updated
